Postreperfusion Syndrome
3 clinical trials · Condition
◉ Watch Postreperfusion Syndrome
| Record | Firm | Date |
|---|---|---|
| Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation (NCT05754242) | Hospital Universitario Ramon y Cajal | 2020-11-17 |
| Comparison of PRS According to Inhalation Agent During LDLT (NCT01886664) | Seoul National University Hospital | 2012-12-01 |
| Effect of Nafamostat on Postreperfusion Syndrome (PRS) (NCT01001403) | Seoul National University Hospital | 2009-03-01 |
Track Postreperfusion Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.